Lucknow: A simple blood test every three months could save the lives of Chronic Obstructive Pulmonary Disease (COPD) patients by predicting sudden flare-ups. These tests can also assess the risk of ...
New Delhi: Chronic obstructive pulmonary disease (COPD), long considered a smoker's disease in old age, is increasingly being diagnosed in people decades younger, new research found. A study published ...
COPD Infection Management and Mitigation Strategies: Focusing on Diagnostics and Targeted Treatments
As the “Swiss Army knife of bacteria,” methicillin-resistant Staphylococcus aureus is quite the problematic organism, said John Osiecki, PhD. Among the diverse group of gram-positive bacteria ...
Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...
Microsoft is betting big on AI. Starting with integrating Bing with ChatGPT, it has implemented AI capabilities in its products. Microsoft Designer is a new product from Microsoft with AI capabilities ...
This analysis examined three phenotypes of pulmonary hypertension (PH) associated with COPD. Patients with end-stage COPD with or without PH had the highest median total emphysema index. Perspective ...
“This new COPD diagnostic schema, which includes chest imaging, respiratory symptoms and spirometry, identified additional individuals at risk of poor respiratory outcomes,” said Bhatt, a professor in ...
Astegolimab every 2 weeks vs placebo statistically significantly reduced the annualized exacerbation rate at week 52 in the ALIENTO trial, but not in the ARNASA trial. Topline data were announced from ...
Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as those of smokers without the disease. These overloaded cells are larger and ...
Sly Stone, an icon of funk music, has died at the age of 82 following a prolonged battle with COPD, a chronic lung condition that can block airflow and cause difficulty breathing. "It is with profound ...
Please provide your email address to receive an email when new articles are posted on . The FDA based mepolizumab’s approval on phase 3 MATINEE and METREX trial results. Mepolizumab has been assessed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback